What is it about?
Ultrsound can biphasically modulate the activity of CPG2, suggesting an adjuvant for the CPG2-prodrug therapy against cancers.
Featured Image
Why is it important?
Ultrasound can be used to modulate the release of active drugs in the CPG2-prodrug therapy
Read the Original
This page is a summary of: Biphasically Modulating the Activity of Carboxypeptidase G2 with Ultrasound, Cellular Physiology and Biochemistry, January 2017, Karger Publishers,
DOI: 10.1159/000479402.
You can read the full text:
Contributors
The following have contributed to this page
